Page 2 - Indian Stock Market

Quick Heal signs cyber security deal with NFSU-RIC; share price jumps 4%

At 9:50 AM, Quick Heal shares were trading 2.24 per cent higher at ₹314.40 per share. In comparison, BSE Sensex was trading 0.35 per cent higher at 86,002.87 levels.

Nuvama starts coverage on Premier Energies with 'Buy', sees J-curve growth

The brokerage argues that Premier Energies is strategically positioning itself to capture exponential growth in the New Energy ecosystem, even as its core solar business remains on solid footing.

Tata Capital primed for strong growth, bank-like returns, says IIFL Capital

IIFL Capital expects TCL's ~15 per cent valuation discount to CIFC to narrow as the company delivers sector-leading earnings momentum.

UBS upgrades Axis Bank; 3 reasons behind bullish view, higher target

UBS believes Axis Bank has moved past the most challenging phase of its operating cycle and is now positioned for a gradual re-rating.

PMI data, US-India trade progress likely to steer markets this week

Domestic PMI data, US Federal Reserve meeting minutes and the progress on India-US trade deal negotiations are likely to influence movement in the equity market in the week ahead, according to analysts. Market direction in the next week will hinge on macro triggers such as domestic PMI data, Federal Reserve meeting minutes and the progress on India-US trade deal negotiations, analysts said. Moreover, the trading activity of foreign investors would also influence the equity market trends. "Looking ahead, market direction will hinge on key macro triggers such as India's PMI data, US jobless claims, FOMC minutes and progress on US-India trade negotiations. "A prudent approach would be to focus on sectors with strong fundamentals, clear earnings visibility, and structural tailwinds -- positioning portfolios for potential upgrades in H2FY26," Vinod Nair, Head of Research, Geojit Investments Ltd, said. Last week, the BSE Sensex surged 1,346.5 points, or 1.62 per cent, while the NSE Nift

Why is Indian stock market down despite NDA lead in Bihar Election 2025?

The Sensex declined up to 0.51 per cent to an intraday low of 84,042.75, while the Nifty50 slipped 0.44 per cent to 25,764.90.

Buy, sell or hold: What to do with Info Edge (India) stock after Q2 show?

Info Edge Share Buy, sell or hold: At 11:30 AM, the Info Edge (India) stock was trading 1.19 per cent lower at ₹1,360.60, even as the BSE Sensex gained 0.33 per cent to 84,743.91.

Bihar Exit Polls, US-India deal: Reasons for Sensex, Nifty rally today

Stock Market Today, Nov 12, 2025: Sensex and Nifty jumped nearly 1% on NDA poll hopes, India-US trade deal optimism, and gains in IT, RIL shares

Petronet Q2: Analysts upbeat on long-term outlook despite FX loss, UoP hit

On the bourses around 10:15 AM, Petronet LNG shares were struggling as the scrip was trading 1.31% lower at ₹273.95. In comparison, BSE Sensex was trading 0.29% lower at 83,289.99 levels.

Sensex can hit 100,000 by June 2026; market correction over: Morgan Stanley

The Indian stock market, Morgan Stanley believes, is transitioning into one that will be driven by macros and stock-picking will likely lose importance

Gurpurab 2025: Stock markets to remain closed for trading today

Stock market is closed today, Nov 5, 2025, for Guru Nanak Jayanti (Gurpurab 2025 holiday). NSE, BSE shut; MCX to open in evening. Check next market holiday and trading schedule

Motilal Oswal raises Nifty EPS, expects steady earnings momentum ahead

Earnings for the 151 MOFSL Universe companies rose 14 per cent year-on-year (Y-o-Y), above the brokerage's 9 per cent estimate.

'India has a can-do spirit': Julius Baer's Mark Matthews at BS BFSI Summit

At the Business Standard BFSI Insight Summit 2025, Julius Baer's Mark Matthews said India's resilience, demographics and 'can-do' spirit keep it a standout in emerging markets

Market maturity fuelled India's IPO boom, say investment bankers

The depth of domestic capital pool has reduced India's reliance on foreign institutional investors, enhancing market stability, a sentiment echoed by most panellists at Business Standard BFSI Summit

SRF's chemicals biz leads Q2 growth; analysts stay bullish; check targets

Brokerages maintained a positive stance on SRF, highlighting continued margin strength, steady volume growth, and the company's strategic capex expansion.

UBS finds emerging markets attractive; India among preferred bets

Improving global and domestic liquidity, persistent underweight positioning by global investors, and a renewed search for geographical diversification further underpin UBS' positive outlook on India

India in sweet spot, has tailwinds to deliver alpha returns: HSBC MF CEO

India's bull run is expected to sustain in Samvat 2082 driven by earnings, consumption, and industrialisation, said Kailash Kulkarni,CEO, HSBC MF

Street Signs: Nifty's pause before glory, MTR Foods GMP at 20%, and more

Nifty stalls near record highs, Orkla India IPO heats up the grey market, and holdcos gear up for a special auction session aimed at unlocking long-trapped value

Nuvama retains 'Hold' on Cipla, raises target after Eli Lilly diabetes deal

Cipla- Eli Lilly deal: Tirzepatide is a prescription drug used for managing type 2 diabetes and aiding weight loss in adults who are obese or overweight.

Here's why Filatex India share price is buzzing in trade today; details

Around 10:00 AM, Filatex India share price was off day's high, but continued to trade 0.9 per cent higher at ₹56.77. In comparison, BSE Sensex was trading 0.87 per cent higher at 85,159.28 levels.